Lannett Receives FDA Approval For Ondansetron Injection, USP 2 Mg/mL Multi-Dose Vials
Links shared publicly online about this topic.
- 1,224total visits
Lannett Receives FDA Approval For Ondansetron Injection, USP 2 Mg/mL Multi-Dose Vials
Lannett Company, Inc. (NYSE AMEX: LCI) announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injec
View full resource at medicalnewstoday.com
Tags: Nausea and Vomiting Medication, Cancer, Drug, FDA, Zofran
Most Recently Shared on April 21, 2010 at 1:21 pm By:
Lannett Receives FDA Approval For Ondansetron Injection, USP 2 Mg/mL Multi-Dose Vials http://mnt.to/3BvX #pharmacy #pharmacist
Also Shared By:
Advertisement
MNT Cancer News
@mnt_cancer
Lannett Receives FDA Approval For Ondansetron Injection, USP 2 Mg/mL Multi-Dose Vials http://mnt.to/3BvX #cancer
1 year ago...